Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-26 @ 2:40 AM
NCT ID: NCT00736502
Description: None
Frequency Threshold: 5
Time Frame: 48 weeks
Study: NCT00736502
Study Brief: PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nevirapine Patients treated with 200 mg Nevirapine twice daily (administered orally). None None 12 278 0 278 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Clostridia enteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 12.1 View
Helicobacter phylori infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 12.1 View
porta catheter infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 12.1 View
Staphylococcus sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 12.1 View
Fracture of foot SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 12.1 View
Hyperkaliemia SYSTEMATIC_ASSESSMENT Investigations MedDRA 12.1 View
Chest pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 12.1 View
Lymphoma of the brain SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 12.1 View
Diabetes insipitus SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 12.1 View
Pneumocystitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 12.1 View
Pneumonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 12.1 View
Enanthema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 12.1 View
Herpes eczema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 12.1 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 12.1 View
Fever SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 12.1 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 12.1 View
Pulmonary embolism SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 12.1 View
Shunt thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 12.1 View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 12.1 View
Lymphadenopathy, generalised SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 12.1 View
Pancytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 12.1 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 12.1 View
Cholecystitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 12.1 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 12.1 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 12.1 View
Pregnancy SYSTEMATIC_ASSESSMENT General disorders MedDRA 12.1 View
Melena SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 12.1 View
Fever SYSTEMATIC_ASSESSMENT General disorders MedDRA 12.1 View
Malaise SYSTEMATIC_ASSESSMENT General disorders MedDRA 12.1 View
Other Events(If Any):